[HTML][HTML] Targeting cyclooxygenase-2 in human neoplasia: rationale and promise
AJ Dannenberg, K Subbaramaiah - Cancer cell, 2003 - cell.com
AJ Dannenberg, K Subbaramaiah
Cancer cell, 2003•cell.comSeveral lines of evidence suggest that cyclooxygenase-2 (COX-2) is a rational target for
anticancer therapy. Epidemiological studies have shown that use of nonsteroidal anti-
inflammatory drugs (NSAIDs), prototypic inhibitors of COX, is associated with a reduced risk
of several malignancies (
anticancer therapy. Epidemiological studies have shown that use of nonsteroidal anti-
inflammatory drugs (NSAIDs), prototypic inhibitors of COX, is associated with a reduced risk
of several malignancies (
Several lines of evidence suggest that cyclooxygenase-2 (COX-2) is a rational target for anticancer therapy. Epidemiological studies have shown that use of nonsteroidal anti-inflammatory drugs (NSAIDs), prototypic inhibitors of COX, is associated with a reduced risk of several malignancies (
cell.com
